Yewande Tolulope Nejo

Yewande Tolulope Nejo

Auto-generated profile, based on publicly available information

Yewande Tolulope Nejo

University of Ibadan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YNYewande T Nejo
Yewande T Nejo
DODavid O Olaleye
David O Olaleye
GOGeorgina N Odaibo
Georgina N Odaibo
Persistent infections with high-risk genital Human papillomavirus (HPV) especially types 16 and 18, are associated with cervical cancer. However, distribution of HPV types varies greatly across geographical regions and the available vaccines target only few types. This study was designed to determine the HPV types circulating in Southwestern Nigeria, thereby providing necessary information for effective control of the virus. Endocervical swab samples were collected from a total of 295 consenting women attending routine cervical cancer screening, STI clinics and community-based outreach programme. Viral DNA was extracted from the samples and the consensus region of the HPV DNA was amplified by PCR using GP-E6/E7 primers. Type-specific nested multiplex PCR and Sanger sequencing were used to genotype the HPV isolates. In this study, 51 (17.3%) individuals were positive for HPV DNA using consensus primers that target the E6/E7 genes but only 48 (16.3%) were genotyped. A total of 15 HPV types (HPV-6, 16, 18, 31, 33, 35, 42, 43, 44, 52, 58, 66, 74, 81, 86) were detected, with HPV-31 being the most predominant (32.8%), followed by HPV-35 (17.2%) and HPV-16 (15.5%). Two rare HPV types; 74 and 86 were also detected. The HPV-74 isolate had three nucleotide (CCT) insertions at E7 gene that translated into amino acid proline. Highest nucleotide substitutions (n = 32) were found in HPV-44 genotype. Among positive individuals, 20.8% had dual infections and 86.2% had High-risk HPV types. Multiple Human papillomavirus types co-circulated in the study. Most of the circulating Human papillomavirus are high-risk type with type 31 being the most predominant. Although the implication of HPV-74 with proline insertion detected for the first time is unknown, it may have effect on the transformation potential of the virus. Polyvalent HPV vaccine will be more effective for the infection control in Nigeria.

14 May 2021 in Virus Genes
Verified
Journal Article
Closed access
PDF file
OOOlukunle Oluwapamilerin Oluwasemowo
Olukunle Oluwapamilerin Oluwasemowo
YNYewande T. Nejo
Yewande T. Nejo
JAJosephine O. Abokede
Josephine O. Abokede
MLMichael Lawson
Michael Lawson
BMBabatunde O. Motayo
Babatunde O. Motayo

1 January 2025 in Journal of Public Health in Africa
Verified
Journal Article
Open access
PDF file
AAAdeponle O. Adeoye
Adeponle O. Adeoye
YNYewande T. Nejo
Yewande T. Nejo
COChinwe Lucia Ochu
Chinwe Lucia Ochu
JBJosephine Bayigga
Josephine Bayigga
RARodgers R. Ayebare
Rodgers R. Ayebare
GOGeorgina Njideka Odaibo
Georgina Njideka Odaibo
Background: COVID-19 disrupted critical public health services globally. It is important to understand how the pandemic affected healthcare service delivery and utilisation in Nigeria to guide planning for future public health crises in the country. Aim: This study aimed to explore how the COVID-19 pandemic affected health service delivery and utilisation in Nigeria. Setting: The study was conducted in Abuja, and Oyo State, Nigeria, in 2023. Methods: This was a cross-sectional qualitative study that adopted an exploratory study design. Key Informant Interviews were used to elicit information from twenty-eight healthcare stakeholders in relevant government health Ministries and Agencies as well as partners of the government on health. The selection of the stakeholders was done through purposive sampling. Recorded interviews were transcribed verbatim, and analysed using an inductive qualitative data analysis method to generate themes. The data were further organized and analysed using NVivo software version 14. Results: The findings revealed that COVID-19 negatively affected healthcare service delivery and utilisation in Nigeria. This was due to various factors such as healthcare workers’ unwillingness to provide services, exposed healthcare system gaps that affected service delivery, and the shift of attention and resources to COVID-19. However, the pandemic also presented an opportunity to improve public health infrastructure and health service delivery. Conclusion: Government needs to maximise the gains from the pandemic to build a resilient health system. Contribution: This article provides insights for public health policy and planning aimed at enhancing resilience and optimising service delivery during future health crises.

1 May 2019 in Scientific African
Verified
Journal Article
Open access
BOBabatunde Olusola
Babatunde Olusola
AFAdedayo Faneye
Adedayo Faneye
YNYewande Nejo
Yewande Nejo
AOAdewale Opayele
Adewale Opayele
SBSolomon Bakarey
Solomon Bakarey

3 May 2024 in Journal of Immunoassay and Immunochemistry
Verified
Journal Article
Closed access
YNYewande Tolulope Nejo
Yewande Tolulope Nejo
OOOlukunle Oluwapamilerin Oluwasemowo
Olukunle Oluwapamilerin Oluwasemowo
EAEsther Ibidunni Ajao
Esther Ibidunni Ajao
MAMiracle Odunayo Ajala
Miracle Odunayo Ajala
OAOluwatosin Felicia Adedire
Oluwatosin Felicia Adedire
AAAnuoluwapo Beauty Alade
Anuoluwapo Beauty Alade
Although a sizable number of pregnant women patronize Traditional Birth Attendants (TBAs) for deliveries in Nigeria, efforts to prevent or reduce the risk of HBV transmission are not targeted at the TBAs and the pregnant women patronizing them. This may be linked to the dearth of information on the serological profiles of HBV among this cohort. We, therefore, show the serological profiles of HBV among the cohort. One hundred and seventy pregnant women and 91 TBAs participated in this study between May and July 2019. Serological markers of HBV infection were assayed using ELISA. A prevalence of, 8.0% (95% CI: 5.0% - 11.5%) for HBsAg, 0.8% (95% CI: 0.0% - 1.9%) for HBeAg, 2.7% (95% CI: 0.8% - 5.0%) for HBcIgM, 26.1% (95% CI: 20.7% - 31.4%) for anti-HBs, 21.5% (95% CI: 16.5% - 25.4%) for anti-HBe and 67.0% (95% CI: 60.9% - 72.8%) for anti-HBc was found indicating a high percentage of carriers. Although 32 (12.3%) of the entire participants claimed to be fully vaccinated, serological evidence was only detected in 4 (12.5%). The high percentage of carriers and low evidence of vaccination necessitate intensified efforts to ensure that adequate interventions are made available and accessible to the TBAs and the pregnant women patronizing them (including newborn babies).

9 January 2024
Verified
Preprint
Open access
PDF file
YNYewande Nejo
Yewande Nejo
OVERALL COMMENTS: The Author has provided some important information on Human papillomavirus (HPV) infection but has failed to point out the aim of the review article. The article is not clearly and accurately written and does not cite current liter...